Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria

Pharmacy Practice

Volumn 7, Issue 3, 2009, Pages 163-169

  Adisa, Rasaq ^a   Alutundu, Martins B ^a   Fakeye, Titilayo O ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Diabetes mellitus; Medication adherence; Nigeria; Type 2

Indexed keywords

ORAL ANTIDIABETIC AGENT;

ARTICLE; BLOOD GLUCOSE MONITORING; DIET RESTRICTION; DRUG COST; DRUG TOLERABILITY; EXERCISE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRESCRIPTION; QUESTIONNAIRE;

EID: 70349206324     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552009000300006     Document Type: Article

References (45)

1. The Expert Committee on Non-communicable Diseases. Non communicable Disease in Nigeria. Final Report of a National Survey, 1997.
2. International Diabetes Federation. Diabetes Prevalence 2005. http-//www.idf.org/home/index.cfm?
3. King H, Rewers M. Global estimates for the prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Reporting Group. Diabetes Care. 1993;16:157-177.
4. Olatunbosun ST, Ojo PO, Fineberg NS, Bella AF. Prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban adults in Nigeria. J Natl Med Assoc. 1998;90:293-301.
5. Helmrich SP, Rayland RW, Leung RS. Paffen- berger, physical activity and reduced occurrence of NIDDM. N Engl J Med. 1991;325(4):147-151.
6. Mark AM, Benjamen W, Van Tassell JL. Medication Nonadherence; An Unrecognized Cardiovascular Risk Factor. Mediscape General Medicine. 2007;9(3):58.
7. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care. 2008;14:71-75.
8. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2.004;27:1218-1224.
9. Schetman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015-1021.
10. Krapek K, King K, Warrien SS, et al. Medication adherence and associated hemoglobin AIC in type 2 diabetes. Ann Pharmcother. 2004;38:1357-1362.
11. The DCCT Research Group: The effect ol intensive treatment of diabetes on the development and progression of long term complications in IDDM. N Engl J Med 1993;329:977-986.
12. Lee WC, Balus Cobden D, Joshl AV, Paphos CL. Prevalence and economic consequerices of medication adherence on diabetes; a systematic literature review. Manag Care Interface. 2006;19:31-41.
13. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
14. Anderson DKG, Svardsudd K: Long term glycemic control relates to mortality in type 2 diabetes. Diabetes Care. 1995; 48:1534-1543.
15. Ohkubo Y, Kishikawa H, Araki E, Isamis S, Motoyoshi, Kojima Y, Furuyoshi N, Scichiri M. Intensive insulin theraphy prevents the progression of diabetic microvascular compilations in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1996;28:103-117.
16. Jacques CHM, Jones RL: Problems encountered by primary care physicians in the care of patients with diabetes. Arch Fam Med. 1993;2:739-741.
17. Lutfey KE, Wishner WJ: Beyond "Compliance" is "adherence". Improving the prospect of diabetes care. Diabetes Care. 1999; 22:635-639.
18. Rubin RR, Peyrot M. Men and Diabetes: Psychosocial and Behavioural issues. Diabetes Spectrum. 1998;11:81-87.
19. Mckay HG, Boles SM, Glasgow RE. Personality (Conscientiousness) and environmental (barriers) factors related to diabetes self management and quality of life. Diabetes Care. 1998;44:170-173.
20. Vileiktye L. Psychological aspects of diabetic peripheral neuropathy. Diabetes Rev. 1999;7:387-393.
21. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in doctor visit- Implications for adherence to diabetic care. Diabetes Care 1996; 19(10):1153-1164.
22. Peterson T, Lee P, Hollis S, Young B, Newton P, Donovan T. Well-being and treatment satisfaction in older people with diabetes. Diabetes Care. 1991;1(3):169-174
23. Diehl AK, Bauer RL, Sugarek N. Correlates of medical compliance in non-insulin dependent diabetes mellitus. Diabetes Care. 1985;8:219-223.
24. Botelho R, Dudrak R. Home Assessment of Adherence to long-term medication in the elderly. J Family Pract. 1992;35:61-64
25. Anderson R, Kirk L. Methods of improving patient compliance in chronic Disease state. Arch Intern Med. 1982;142:1673-1675.
26. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications, estimates and projection to the year 2010. Diabetic Medicine. 1997;14(suppl 5):S1-S85.
27. Unwin N, Sobugwi E, Alberto KGMM. Type 2 diabetes: the challenge of preventing a global epidemic. Diabetes Int. 2001;11:4-8.
28. World Health Organization. Prevention of diabetes mellitus. Report of a WHO study Group. WHO Technical Report Series 844. Geneva WHO, 1994.
29. StatDirect-Statistical software which link to Microsoft Excel. http://statdirect.com/
30. Epilnfo-free epidemiology/statistics software from CDC, Atlanta. http://www.cdc.gov/epiinfo/
31. Sample size Tables for clinical studies (2nd Edition, 1997) by Machin D, Campbell M, Fayers P & Pinol A- Published by Blackwell Science Ltd (ISBN 0-86542-870-0).
32. Paes AH, Baker A, Soc-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997;20:1512-1517.
33. Dunbar J. Predictors of patient adherence: Patient characteristics. In Shumaker S., Eleanor B., (Eds). The handbook of health behaviour change 1990. New York, NY, USA: Springer Publishing Co Inc.
34. Talbot F, Nouwen A, Gingras J. Relations of Diabetes Intrusiveness and Personal Control to Symptoms of Depression Among Adults With Diabetes, Health Psychol. 1999; 18:537-542.
35. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ.Effect of Medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836-1841.
36. Ary DV, Toobert D, Wilson W, Glasgow RE. Patient perspective an factors contributing to nonadherence to diabetes regimen. Diabetes Care 1986; 9:168-172.
37. Jayant D, Lawrence B, Richard G. Factor Influencing Patient Acceptability of Diabetes Treatment Regimens. Clinical Diabetes 2000; Vol 18 No2 Spring
38. Korzon-Burakowska A, Hopkins D, Matyka K, Lomas J, Pernet A, Macdonald I, Amiel S. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes. Diabetes Care. 1998;21(2):283-290.
39. Hsaio LD, Salmon JW. Predicting adherence to prescription medication purchase among HMO enrollees with diabetes. J Manag Care Pharm. 1999;5(4):336-341.
40. Linda CC. Health education and Health promotion (In): Suzame CS &Brenda GB. (Eds) Brunner and Sudddarth's textbook of medical surgical nursing (10th edition), Lippincott William and Wilkins; 2001 Pp 46-47.
41. Ohene Buabeng K, Motowel L, Plange-Rhule J. Unaffordable drug prices: the major cause of noncompliance with hypertensive medication in Ghana. J Pharm Sci. 2004;7:350-352.
42. Harris MI, Cowie CC, Howie LJ. Self monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care 1993; 16:1116-1123.
43. Vik SA, Maxwell CJ, Hogan DB, Patten SB, Johnson JA, Romonko-Slack L. Assessing medication adherence among older persons in community settings. Can J Clin Pharmacol. 2005;12(1):eI52-eI64.
44. Gordis L, Markowitz M, Lilienfield AM. The inaccuracy in using interviews to estimate patient reliability in taking medication at home. Med Care. 1969;7(1):49-54.
45. Morisky DE, Green LW, Levine DM. Current and predictive validity of a self reported measure of meditation adherence. Med Care. 1986;24:67-74.